BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16142236)

  • 1. Identification of mutations in CUL7 in 3-M syndrome.
    Huber C; Dias-Santagata D; Glaser A; O'Sullivan J; Brauner R; Wu K; Xu X; Pearce K; Wang R; Uzielli ML; Dagoneau N; Chemaitilly W; Superti-Furga A; Dos Santos H; Mégarbané A; Morin G; Gillessen-Kaesbach G; Hennekam R; Van der Burgt I; Black GC; Clayton PE; Read A; Le Merrer M; Scambler PJ; Munnich A; Pan ZQ; Winter R; Cormier-Daire V
    Nat Genet; 2005 Oct; 37(10):1119-24. PubMed ID: 16142236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CUL7: A DOC domain-containing cullin selectively binds Skp1.Fbx29 to form an SCF-like complex.
    Dias DC; Dolios G; Wang R; Pan ZQ
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16601-6. PubMed ID: 12481031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cullin7 E3 ubiquitin ligase: a novel player in growth control.
    Sarikas A; Xu X; Field LJ; Pan ZQ
    Cell Cycle; 2008 Oct; 7(20):3154-61. PubMed ID: 18927510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal uniparental isodisomy and heterodisomy on chromosome 6 encompassing a CUL7 gene mutation causing 3M syndrome.
    Sasaki K; Okamoto N; Kosaki K; Yorifuji T; Shimokawa O; Mishima H; Yoshiura KI; Harada N
    Clin Genet; 2011 Nov; 80(5):478-83. PubMed ID: 21166787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A large-scale mutation search reveals genetic heterogeneity in 3M syndrome.
    Huber C; Delezoide AL; Guimiot F; Baumann C; Malan V; Le Merrer M; Da Silva DB; Bonneau D; Chatelain P; Chu C; Clark R; Cox H; Edery P; Edouard T; Fano V; Gibson K; Gillessen-Kaesbach G; Giovannucci-Uzielli ML; Graul-Neumann LM; van Hagen JM; van Hest L; Horovitz D; Melki J; Partsch CJ; Plauchu H; Rajab A; Rossi M; Sillence D; Steichen-Gersdorf E; Stewart H; Unger S; Zenker M; Munnich A; Cormier-Daire V
    Eur J Hum Genet; 2009 Mar; 17(3):395-400. PubMed ID: 19225462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a regulatory role of Cullin-RING E3 ubiquitin ligase 7 in insulin signaling.
    Scheufele F; Wolf B; Kruse M; Hartmann T; Lempart J; Mühlich S; Pfeiffer AFH; Field LJ; Charron MJ; Pan ZQ; Engelhardt S; Sarikas A
    Cell Signal; 2014 Feb; 26(2):233-239. PubMed ID: 24219910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of the Fbxw8 gene results in pre- and postnatal growth retardation in mice.
    Tsutsumi T; Kuwabara H; Arai T; Xiao Y; Decaprio JA
    Mol Cell Biol; 2008 Jan; 28(2):743-51. PubMed ID: 17998335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cullin 7 and Fbxw 8 expression in trophoblastic cells is regulated via oxygen tension: implications for intrauterine growth restriction?
    Fahlbusch FB; Dawood Y; Hartner A; Menendez-Castro C; Nögel SC; Tzschoppe A; Schneider H; Strissel P; Beckmann MW; Schleussner E; Ruebner M; Dörr HG; Schild RL; Rascher W; Dötsch J
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2209-15. PubMed ID: 22524683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, molecular and histopathological features of short stature syndrome with novel CUL7 mutation in Yakuts: new population isolate in Asia.
    Maksimova N; Hara K; Miyashia A; Nikolaeva I; Shiga A; Nogovicina A; Sukhomyasova A; Argunov V; Shvedova A; Ikeuchi T; Nishizawa M; Kuwano R; Onodera O
    J Med Genet; 2007 Dec; 44(12):772-8. PubMed ID: 17675530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin ligase cullin 7 induces epithelial-mesenchymal transition in human choriocarcinoma cells.
    Fu J; Lv X; Lin H; Wu L; Wang R; Zhou Z; Zhang B; Wang YL; Tsang BK; Zhu C; Wang H
    J Biol Chem; 2010 Apr; 285(14):10870-9. PubMed ID: 20139075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the Cullin7 E3 ubiquitin ligase--heterodimerization of cullin substrate receptors as a novel mechanism to regulate cullin E3 ligase activity.
    Ponyeam W; Hagen T
    Cell Signal; 2012 Jan; 24(1):290-5. PubMed ID: 21946088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the spectrum of 3-M syndrome, a primordial short stature disorder of disrupted ubiquitination.
    Clayton PE; Hanson D; Magee L; Murray PG; Saunders E; Abu-Amero SN; Moore GE; Black GC
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):335-42. PubMed ID: 22624670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cullin 7 in tumor development: a novel potential anti-cancer target.
    Li Y; Zang A; Fu J; Jia Y
    Neoplasma; 2021 May; 68(3):572-579. PubMed ID: 33618520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of two CUL7 variants in two Chinese families with 3-M syndrome by whole-exome sequencing.
    Hu L; Wang X; Jin T; Han Y; Liu J; Jiang M; Yan S; Fu X; An B; Huang S
    J Clin Lab Anal; 2020 Jul; 34(7):e23265. PubMed ID: 32141654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases.
    Zhou W; Wei W; Sun Y
    Cell Res; 2013 May; 23(5):599-619. PubMed ID: 23528706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic localized ubiquitin ligase cullin 7 binds to p53 and promotes cell growth by antagonizing p53 function.
    Andrews P; He YJ; Xiong Y
    Oncogene; 2006 Aug; 25(33):4534-48. PubMed ID: 16547496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cullin-RING E3 Ubiquitin Ligase 7 in Growth Control and Cancer.
    Pan ZQ
    Adv Exp Med Biol; 2020; 1217():285-296. PubMed ID: 31898234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fbxw8 is essential for Cul1-Cul7 complex formation and for placental development.
    Tsunematsu R; Nishiyama M; Kotoshiba S; Saiga T; Kamura T; Nakayama KI
    Mol Cell Biol; 2006 Aug; 26(16):6157-69. PubMed ID: 16880526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SCF(HOS/beta-TRCP)-ROC1 E3 ubiquitin ligase utilizes two distinct domains within CUL1 for substrate targeting and ubiquitin ligation.
    Wu K; Fuchs SY; Chen A; Tan P; Gomez C; Ronai Z; Pan ZQ
    Mol Cell Biol; 2000 Feb; 20(4):1382-93. PubMed ID: 10648623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OBSL1 mutations in 3-M syndrome are associated with a modulation of IGFBP2 and IGFBP5 expression levels.
    Huber C; Fradin M; Edouard T; Le Merrer M; Alanay Y; Da Silva DB; David A; Hamamy H; van Hest L; Lund AM; Michaud J; Oley C; Patel C; Rajab A; Skidmore DL; Stewart H; Tauber M; Munnich A; Cormier-Daire V
    Hum Mutat; 2010 Jan; 31(1):20-6. PubMed ID: 19877176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.